DNA Stock Overview
Engages in the hotel accommodation, gaming, and leisure businesses in Australia, Cambodia, Vietnam, Singapore, Malaysia, and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Donaco International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.027 |
| 52 Week High | AU$0.048 |
| 52 Week Low | AU$0.026 |
| Beta | 1.14 |
| 11 Month Change | -10.00% |
| 3 Month Change | -18.18% |
| 1 Year Change | -28.95% |
| 33 Year Change | -37.21% |
| 5 Year Change | -63.01% |
| Change since IPO | -93.72% |
Recent News & Updates
These 4 Measures Indicate That Donaco International (ASX:DNA) Is Using Debt Safely
Oct 11
A Piece Of The Puzzle Missing From Donaco International Limited's (ASX:DNA) Share Price
Aug 26Donaco International (ASX:DNA) Is Doing The Right Things To Multiply Its Share Price
Jul 04Donaco International Limited (ASX:DNA) Doing What It Can To Lift Shares
Apr 24Recent updates
These 4 Measures Indicate That Donaco International (ASX:DNA) Is Using Debt Safely
Oct 11A Piece Of The Puzzle Missing From Donaco International Limited's (ASX:DNA) Share Price
Aug 26Donaco International (ASX:DNA) Is Doing The Right Things To Multiply Its Share Price
Jul 04Donaco International Limited (ASX:DNA) Doing What It Can To Lift Shares
Apr 24Is Donaco International (ASX:DNA) Using Too Much Debt?
Mar 06Donaco International (ASX:DNA) Is Finding It Tricky To Allocate Its Capital
Jan 31Donaco International (ASX:DNA) Has A Somewhat Strained Balance Sheet
Dec 06Is Donaco International (ASX:DNA) Using Too Much Debt?
Mar 14Does Donaco International (ASX:DNA) Have A Healthy Balance Sheet?
Sep 01Here's Why Donaco International (ASX:DNA) Can Afford Some Debt
Apr 06Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)
Sep 07Is Donaco International (ASX:DNA) A Risky Investment?
May 26How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Here's Why Donaco International (ASX:DNA) Can Afford Some Debt
Dec 25
Shareholder Returns
| DNA | AU Hospitality | AU Market | |
|---|---|---|---|
| 7D | -6.9% | 4.7% | 1.4% |
| 1Y | -28.9% | 23.0% | 17.7% |
Return vs Industry: DNA underperformed the Australian Hospitality industry which returned 23% over the past year.
Return vs Market: DNA underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
| DNA volatility | |
|---|---|
| DNA Average Weekly Movement | 10.8% |
| Hospitality Industry Average Movement | 6.2% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: DNA has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: DNA's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Techatut Sukjaroenkraisri Huy | www.donacointernational.com/IRM/content/default.aspx |
Donaco International Limited, together with its subsidiaries, engages in the hotel accommodation, gaming, and leisure businesses in Australia, Cambodia, Vietnam, Singapore, Malaysia, and Hong Kong. It operates Star Vegas Resort and Club, a casino and hotel complex in Poipet, Cambodia; and Aristo International Hotel, a boutique casino and resort complex in northern Vietnam. Donaco International Limited is based in Sydney, Australia.
Donaco International Limited Fundamentals Summary
| DNA fundamental statistics | |
|---|---|
| Market cap | AU$33.32m |
| Earnings (TTM) | AU$37.06m |
| Revenue (TTM) | AU$39.53m |
0.9x
P/E Ratio0.8x
P/S RatioIs DNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DNA income statement (TTM) | |
|---|---|
| Revenue | AU$39.53m |
| Cost of Revenue | AU$13.46m |
| Gross Profit | AU$26.07m |
| Other Expenses | -AU$10.99m |
| Earnings | AU$37.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 65.94% |
| Net Profit Margin | 93.75% |
| Debt/Equity Ratio | 10.4% |
How did DNA perform over the long term?
See historical performance and comparison